PositiveID Corp. has submitted to the Food and Drug Administration a 510(k) pre-market notification application for its "iglucose" technology to better manage diabetes. FDA 510(k) clearance is necessary before the product can be commercially available.
All Health Data Management articles are archived after 7 days. REGISTER NOW for unlimited access to all recently archived articles, as well as thousands of searchable stories. Registered Members also gain access to exclusive industry white paper downloads, web seminars, podcasts, e-books, and conference discounts. Qualified members may also choose to receive our free monthly magazine and any of our e-newsletters covering the latest breaking news, opinions from industry leaders, developing trends and specialized topics like EHR's, revenue cycle management, health insurance exchanges, analytics, and more!